| Literature DB >> 35298727 |
Abdelazeem M Algammal1, Reham M El-Tarabili2, Khyreyah J Alfifi3, Amenah S Al-Otaibi3, Marwa E Abo Hashem2, Mamdouh M El-Maghraby4, Ahmed E Mahmoud4.
Abstract
Shiga-toxigenic Escherichia coli (STEC) is incriminated in severe hemorrhagic enteritis in dogs, which is considered a veterinary and public health alarm. To investigate the prevalence, antimicrobial resistance patterns, virulence determinants, and distribution of antimicrobial resistance genes in STEC strains isolated from dogs: 80 fecal samples were obtained from diseased dogs suffering from hemorrhagic diarrhea from pet animal clinics in Ismailia governorate, Egypt. The obtained samples were examined bacteriologically. Moreover, the retrieved isolates were tested for serogrouping, Congo-red binding, antimicrobial resistance, and PCR-based determination of virulence and antimicrobial resistance genes. The prevalence of E. coli in the examined diseased dogs was 23.75% (19/80). The serogrouping of the recovered isolates revealed that 84.2% of the tested isolates were distributed into three serogroups: O146 (36.8%), O111 (31.5%), and O26 (15.7%). Meanwhile, three isolates were untypable (15.8%). Moreover, all the tested E. coli serovars were positive for CR-binding. PCR revealed that the prevalence of stx1, eaeA, hlyA, and stx2 virulence genes was 100%, 100%, 100%, and 47.3%, respectively. Our findings revealed that 31.5% of the recovered isolates showed MDR to five antimicrobial classes and harbored blaTEM, blaCTX-M, tetA, tetB, and sul1 genes. Alarmingly, three isolates were carbapenem-resistant. Two strains harbored the blaKPC gene, while one strain carried the blaNDM-1 gene. Concisely, as far as we know, this is the first study that reported the existence of MDR-STEC in dogs in Egypt. The stx1 gene is the most predominant Shiga toxin gene that accompanied the STEC isolated from hemorrhagic enteritis in dogs. The emerging MDR-STEC in dogs commonly harbors blaTEM, blaCTX-M, sul1, tetA, tetB, and qnrA resistance genes. Meropenem, levofloxacin, and tigecycline exhibited talented antimicrobial activity against MDR-STEC isolated from dogs.Entities:
Keywords: Antibiogram; Antimicrobial resistance genes; Dogs; MDR; STEC; Virulence determinants
Year: 2022 PMID: 35298727 PMCID: PMC8931135 DOI: 10.1186/s13568-022-01371-4
Source DB: PubMed Journal: AMB Express ISSN: 2191-0855 Impact factor: 3.298
Oligonucleotides sequences and cycling conditions of PCR assay
| Target genes | Primers sequences | Amplicon size (bp) | Reaction volume (µL) | Amplification (35 cycles) | References | ||
|---|---|---|---|---|---|---|---|
| Denat | Annealing | Extension | |||||
ATGCTTAGTGCTGGTTTAGG GCCTTCATCATTTCGCTTTC | 248 | 25 | 94 ˚C 30 s | 51 ˚C 30 s | 72 ˚C 30 s | (Bisi-Johnson et al. | |
AACAAGGATAAGCACTGTTCTGGCT ACCATATAAGCGGTCATTCCCGTCA | 1177 | 25 | 94 ˚C 30 s | 54 ˚C 40 s | 72 ˚C 45 s | (Piva et al. | |
ACACTGGATGATCTCAGTGG CTGAATCCCCCTCCATTATG | 614 | 50 | 94 ˚C 30 s | 58 ˚C 40 s | 72 ˚C 45 s | (Dipineto et al. | |
CCATGACAACGGACAGCAGTT CCTGTCAACTGAGCAGCACTTTG | 779 | ||||||
CGGCGTGGGCTACCTGAACG GCCGATCGCGTGAAGTTCCG | 433 | 25 | 94 ˚C 30 s | 55 ˚C 45 s | 72 ˚C 45 s | (Ibekwe et al. | |
GGTTCACTCGAACGACGTCA CTGTCCGACAAGTTGCATGA | 576 | 50 | 94 ˚C 30 s | 55 ˚C 40 s | 72 ˚C 45 s | (Randall | |
CCTCAGCTTCTCAACGCGTG GCACCTTGCTCATGACTCTT | 634 | ||||||
AGAGGATTTCTCACGCCAGG TGCCAGGCACAGATCTTGAC | 580 | 50 | 95 ˚C 1 min | 54 ˚C 1 min | 72 ˚C 1 min | (Cattoir et al. | |
GGMATHGAAATTCGCCACTG TTTGCYGYYCGCCAGTCGAA | 264 | ||||||
GCAAGTTCATTGAACAGGGT TCTAAACCGTCGAGTTCGGCG | 428 | ||||||
ATGTGCAGYACCAGTAARGTKATGGC TGGGTRAARTARGTSACCAGAAYCAGCGG | 593 | 25 | 94 ˚C 30 s | 54 ˚C 40 s | 72 ˚C 45 s | (Archambault et al. | |
ATCAGCAATAAACCAGC CCCCGAAGAACGTTTTC | 516 | 25 | 94 ˚C 30 s | 54 ˚C 40 s | 72 ˚C 45 s | (Colom et al. | |
ATGTCACTGTATCGCCGTCT TTACTGCCCGTTGACGCCC | 892 | 25 | 94 ˚C 1 min | 55 ˚C 1 min | 72 ˚C 1 min | (Xia et al. | |
GGCGGAATGGCTCATCACGA CGCAACACAGCCTGACTTTC | 287 | 25 | 94 ˚C 30 s | 55 ˚C 30 s | 72 ˚C 30 s | ||
Antibiogram profiles of the recovered E. coli isolates (n = 19)
| Antimicrobial classes | Antimicrobial agents | Sensitive | Intermediate | Resistant | |||
|---|---|---|---|---|---|---|---|
| % | % | % | |||||
| Penicillins | Amoxicillin (AMX) | 3 | 15.8 | 0 | 0 | 16 | 84.2 |
| Amoxicillin-Clavulanic acid (AMC) | 1 | 5.2 | 5 | 26.3 | 13 | 68.4 | |
| Cephalosporins | Cefotaxime (CTX) | 2 | 10.5 | 9 | 47.3 | 8 | 42.1 |
| Ceftazidime (CAZ) | 0 | 0 | 11 | 57.9 | 8 | 42.1 | |
| Carbapenems | Meropenem (MEM) | 15 | 78.94 | 1 | 5.26 | 3 | 15.8 |
| Sulfonamide | Trimethoprim-Sulfamethoxazole (SXT) | 0 | 0 | 0 | 0 | 19 | 100 |
| Aminoglycoside | Amikacin (AK) | 3 | 15.8 | 13 | 68.4 | 3 | 15.7 |
| Glycylcycline | Tigecycline (TCG) | 12 | 63.2 | 7 | 36.8 | 0 | 0 |
| Fluroquinolones | Levofloxacin (LEV) | 12 | 63.2 | 0 | 0 | 7 | 36.8 |
| Monobactam | Aztreonam (ATM) | 11 | 57.9 | 8 | 42.1 | 0 | 0 |
| Tetracycline | Tetracycline (TE) | 0 | 0 | 0 | 0 | 19 | 100 |
| Polymyxins | Colistin sulfate (CT) | 9 | 47.3 | 2 | 10.5 | 8 | 42.1 |
| Chi square | 62.235 | 54.143 | 58.231 | ||||
*Significant differences were noticed between AMX and TCG: X2 = 7.6842, p = 0.02145, AMX and ATM: X2 = 7.6842, p = 0.02145, AMX and SXT: X2 = 7.6842, p = 0.02145, AMX and TE: X2 = 7.6842, p = 0.02145, AMX and LEV: X2 = 6.107, p = 0.047, CTX and CAZ: X2 = 15.119, p < 0.0001, CAZ and CT: X2 = 15.119, p < 0.0001, MEM and TCG: X2 = 8.8947, p = 0.00286, MEM and ATM: X2 = 8.8947, p = 0.00286, MEM and TE: X2 = 8.8947, p = 0.00286, MEM and SXT: X2 = 8.8947, p = 0.00286, MEM and AK: X2 = 12.223, p < 0.0001, SXT and AK: X2 = 8.8947, p = 0.00286, TE and AK: X2 = 8.8947, p = 0.00286, AK and ATM: X2 = 8.8947, p = 0.00286, AK and TCG: X2 = 8.8947, p = 0.00286
Fig. 1The heat map describes the susceptibility of the recovered E. coli isolates to various tested antimicrobial agents
Fig. 2The heat map describes the correlation among different antimicrobial agents
Fig. 3The dissemination of virulence determinants and antimicrobial resistance genes between the retrieved E. coli isolates
The distribution of multidrug-resistance patterns and the corresponding-resistance genes among the tested E. coli isolates (n = 19)
| No. of strains | % | Resistance type | Phenotypic multidrug resistance patterns | Antimicrobial-resistance genes |
|---|---|---|---|---|
| 6 | 31.5 | MDR | Five classes AMX and AMC CAZ and CTX SXT TE CT | |
| 5 | 26.3 | MDR | Four classes AMX and AMC LEV SXT TE | |
| 2 | 10.5 | MDR | Seven classes AMX and AMC CAZ and CTX MEM AK SXT TE CT | |
| 2 | 10.5 | MDR | Four classes AMX LEV SXT TE | |
| 1 | 5.2 | MDR | Five classes AMX MEM AK SXT TE |
The distribution of Phenotypic resistance patterns, virulence and antimicrobial resistance genes between the retrieved E. coli serogroups (n = 19)
| Serogroups | Phenotypic resistance | Genotypic resistance | MAR index | Virulence genes | Resistance type |
|---|---|---|---|---|---|
| O111 | SXT, AMX, AMC, TE, CAZ, CTX, CT | 0.58 | MDR | ||
| O146 | SXT, AMX, AMC, LEV, TE | 0.41 | MDR | ||
| Untyped | SXT, TE | 0.2 | R | ||
| O111 | SXT, AMX, AMC, CTX, CAZ, TE, CT | 0.58 | MDR | ||
| Untyped | SXT, TE | 0.2 | R | ||
| O111 | SXT, AMX, AMC, CTX, CAZ, TE, CT | 0.58 | MDR | ||
| O111 | SXT, AMX, AMC, CTX, CAZ, TE, CT | 0.58 | MDR | ||
| O146 | SXT, AMX, AMC, LEV, TE | 0.41 | MDR | ||
| O146 | SXT, AMX, LEV, TE | 0.41 | MDR | ||
| O146 | SXT, AMX, AMC, LEV, TE | 0.41 | MDR | ||
| O146 | SXT, AMX, AMC, LEV, TE | 0.41 | MDR | ||
| O26 | SXT, AMX, AMC, CAZ, CTX, MEM, CT, AK, TE | 0.75 | MDR | ||
| O146 | SXT, AMX, AMC, LEV, TE | 0.41 | MDR | ||
| O111 | SXT, AMX, AMC, CAZ, CTX, TE | 0.58 | MDR | ||
| O26 | SXT, AMX, MEM, AK, TE | 0.5 | MDR | ||
| O146 | SXT, AMX, LEV, TE | 0.41 | MDR | ||
| O26 | SXT, AMX, AMC, CAZ, CTX, MEM, CT, AK, TE | 0.75 | MDR | ||
| O111 | SXT, AMX, AMC, CTX, CAZ, TE, CT | 0.6 | MDR | ||
| Untyped | SXT, TE | 0.2 | R |
MAR multiple antibiotic resistance = (a/b)
Fig. 4The heat map shows the correlation between virulence genes, the antimicrobial-resistance genes, and the retrieved STEC serovars
Fig. 5The heat map shows the correlation between the phenotypic antibiotic-resistant and corresponding genes